Amyloid Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Amyloid stocks.

Amyloid Stocks Recent News

Date Stock Title
Oct 1 LLY U.S. port strike expected to have limited impact on healthcare supply chain: HHS
Oct 1 LLY Here's how AI is set to disrupt healthcare — albeit slowly
Oct 1 LLY t:slim X2's Compatibility With Lilly's Lyumjev Might Aid TNDM Stock
Oct 1 LLY Market Chatter: Eli Lilly Mulls Testing Weight-Loss Drugs on People With Normal Weight
Oct 1 LLY Lilly looking to test Zepbound as health maintenance drug: report
Oct 1 LLY Roche Ramps Up Breast Cancer Pipeline With Regor's CDK Inhibitors
Oct 1 ALNY Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
Oct 1 IONS Ionis gets U.S. FDA fast track designation for its Alexander disease treatment
Oct 1 LLY Eli Lilly Aims To Expand Weight-Loss Drug Trials To Those At Risk, Not Just Overweight
Oct 1 ALNY Not Holding Alnylam Pharmaceuticals (ALNY) Hurt Fidelity Growth Strategies Fund’s Performance
Oct 1 ABUS Arbutus to Present at H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference
Oct 1 NTLA Intellia Therapeutics to Present New Clinical Data from the Phase 1 Study of nexiguran ziclumeran (nex-z) for the Treatment of Transthyretin (ATTR) Amyloidosis at the 2024 AHA Scientific Sessions
Oct 1 IONS Zilganersen granted U.S. FDA Fast Track designation for people living with Alexander disease
Oct 1 BBIO 5 FDA decisions to watch in the fourth quarter
Sep 30 LLY Tradepulse Power Inflow Alert: Eli Lilly And Company Climbs 15 Points
Sep 30 ABOS Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
Sep 30 LLY Sanofi, Regeneron's Dupixent Gets FDA Approval for COPD
Sep 30 LLY Bayer Reports Positive Safety Data on Parkinson's Disease Drug
Sep 30 PRTA Dow Dips 300 Points; Emcore Shares Spike Higher
Sep 30 LLY Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate
Amyloid

Amyloids are aggregates of proteins characterised by a fibrillar morphology of 7–13 nm in diameter, a β-sheet secondary structure (known as cross-β) and ability to be stained by particular dyes, such as Congo red. In the human body, amyloids have been linked to the development of various diseases. Pathogenic amyloids form when previously healthy proteins lose their normal structure and physiological functions (misfolding) and form fibrous deposits in plaques around cells which can disrupt the healthy function of tissues and organs.
Such amyloids have been associated with (but not necessarily as the cause of) more than 50 human diseases, known as amyloidosis, and may play a role in some neurodegenerative disorders. Some of these diseases are mainly sporadic and only a few cases are familial. Others are only familial. Some are iatrogenic as they result from medical treatment. One amyloid protein is infectious and is called prion in which the infectious form can act as a template to convert other non-infectious proteins into infectious form. Amyloids may also have normal biological functions; for example, in the formation of fimbriae in some genera of bacteria, transmission of epigenetic traits in fungi, as well as pigment deposition and hormone release in humans.Amyloids have been known to arise from many different proteins. These polypeptide chains generally form β-sheet structures that aggregate into long fibers; however, identical polypeptides can fold into multiple distinct amyloid conformations. The diversity of the conformations may have led to different forms of the prion diseases.

Browse All Tags